The effect of buffered pH solutions on <i>A</i>. <i>hispidus</i> germination from populations sampled in Frederick, MD, Lincoln, MO, and Williamsburg, VA (Table 1). by Michael C. Beall (18764654)

An Analysis of Porphyrin Molecular FlexibilityUse of Porphyrin Diacids by Beisong Cheng (2970567)

“…Molecular mechanics calculations, using a modified version of MM2(87) and a newly developed force field for porphyrin diacids, correctly predict that the flexibility of <i>meso</i>-tetraaryl porphyrin diacids decreases as the steric bulk of the peripheral substituents increases:  [H₄TPyP]²⁺ ≈ [H₄TPP]²⁺ > [H₄T-2,6-(OH)₂ PP]²⁺ ≈ [H₄T-2,6-F₂ PP]²⁺ > [H₄T-2,6-Cl₂ PP]²⁺ ≈ [H₄TMP]²⁺. …”

Sensitivity analysis of the lag time steps and maximum growth rate simulations from (A) and (B): Fig 5C, (C) and (D): Fig 6C, (E) and (F): Fig 9C and 9F. by Zoe Nahas (22250651)

Induction of duodenal and hepatic Cyps in VD₃ deficient mice after DEX treatment. by Kavya Annu (11587215)

PKCη phosphorylated occludin from decreased Na^<b>+</b>/K^<b>+</b>-ATPase activity is a mechanism for noise-induced blood-labyrinth barrier disruption. by Yue Yang (52715)

“…G, Immunoblots for occludin from NE mice pre-treated with PKCηNC and PKCηPS. H, A 2.4-fold decrease in the (α/β) ratio occurred with PKCηPS pre-treatment (*P = 0.022<0.05). …”

Plasma DEX concentrations in C57BL/6 VD₃ sufficient and deficient mice on a discontinuous DEX regimen. by Kavya Annu (11587215)

Cyp and transporter gene expression in duodenum of VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

No protection against influenza infection in mice immunized with the double restricted epitopes. by Sara Ram Pedersen (843509)

Predicting Vulnerabilities of North American Shorebirds to Climate Change by Hector Galbraith (636637)

“…No species was reclassified into a lower–risk category, although 6 species had at least one risk factor decrease in association with climate change. …”

PTX frequency (per year). by Yukiko Namba (6829589)

Subjects:

Univariate and multivariate analyses of PTX frequency per year (N = 147). by Yukiko Namba (6829589)

Subjects:

Proportions of PTX episodes for males and females by age (N = 149). by Yukiko Namba (6829589)

Subjects:

Clinical features of the probands at presentation. by Yukiko Namba (6829589)

Subjects:

Characteristics of BHDS patients by presenting features (N = 334). by Yukiko Namba (6829589)

Subjects:

Characteristics of PTX in BHDS patients (N = 314). by Yukiko Namba (6829589)

Subjects:

Kaplan–Meier estimates of developing the first PTX (N = 314). by Yukiko Namba (6829589)

Subjects:

Univariate and multivariate analyses of the age at the first PTX episode (N = 312). by Yukiko Namba (6829589)

Subjects:

Data set. by Yukiko Namba (6829589)

Subjects:

Characteristics of BHDS patients (N = 334). by Yukiko Namba (6829589)

Subjects:

The anti-HCMV CRISPR/Cas9 system induces mutations resulting in a decrease in IE protein expression in primary fibroblasts. by Janina Gergen (4856863)